Identification of high risk patients with endometrial carcinoma. Prognostic assessment of endometrial cancer

European Journal of Gynaecological Oncology

Volumn 23, Issue 3, 2002, Pages 216-220

  Mangili, G ^a   De Marzi, P ^a   Vigano R ^a   Rabaiotti, E ^a   Sassi, I ^a   Taccagni, G L ^a   Garancini, P ^a   Frigerio, L ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Endometrial cancer; Ploidy; Prognostic factors

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RISK; CYTOLOGY; ENDOMETRIUM CARCINOMA; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PLOIDY; PROGNOSIS; AGE; CANCER STAGING; DISEASE FREE SURVIVAL; ENDOMETRIUM TUMOR; GENETICS; ITALY; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; ENDOMETRIAL NEOPLASMS; FEMALE; HUMAN; ITALY; LYMPHATIC METASTASIS; MIDDLE AGE; NEOPLASM STAGING; PLOIDIES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS; HUMANS; MIDDLE AGED;

DNA;

EID: 0035986030     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Prognostic factors in early carcinoma of the endometrium
2. Relationship between surgical pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium
3. Annual report on the results of treatment in gynecological cancer. Radimhemmet, Stockholm
4. Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma
5. Risk groups and adjuvant therapy in surgical staged endometrial cancer patients. A randomized multicenter study comparing chemotherapy with radiation therapy
6. Method for analysis of cellular DNA content of paraffin embedded pathological material using flow cytometry
7. Guidelines for implementation of clinical DNA cytometry
8. DNA aneuploidy in adenomas of endocrine organs
9. Nonparametric estimation from incomplete observation
10. Regression models and life tables
11. Surgical pathologic spread patterns of endometrial cancer. A gynecologic Oncologic Group Study
12. Surgical pathologic staging in apparent stage I endometrial carcinoma
13. Five year survival rate in endometrial carcinoma stage I-II: Influence of degree or tumor differentiation, age, myometrial invasion and DNA content
14. Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: Comparison with other clinical-pathologic parameters
15. Endometrial adenocarcinoma in Norway
16. Surgical pathological staging of endometrial carcinoma and results of treatment
17. The prognostic significance of surgical staging for carcinoma of the endometrium
18. Pelvic lymph node metastasis in endometrial cancer with no myometrial invasion
19. Evaluation of DNA ploidy in endometrial cancer
20. Preoperative evaluation of tumor ploidy in endometrial carcinoma. An accurate tool to identify patients at risk for extrauterine disease and recurrence
21. Tumor ploidy as a major prognostic factor in advanced ovarian cancer
22. Prediction of long term survival by flow cytometric analysis of cellular DNA content in patients with advanced ovarian cancer
23. Prognostic significance of DNA index, multiploidy, and S-phase fraction in ovarian cancer
24. Ploidy disturbances in endometrial and ovarian carcinomas. A review
25. Prognostic significance of ploidy level in human tumors. Carcinoma of the uterus
26. The prognostic significance of DNA measurement in endometrial carcinoma
27. Flow cytometric deoxyribonucleic acid index: A prognostic factor in endometrial carcinoma
28. Flow cytometric DNA analysis of normal and cancerous human endometrium and cytological-histopathological correlations
29. Prognostic value of flow cytometric DNA measurements in stage I-II endometrial carcinoma: Correlations with steroid receptor concentrations, tumor myometrial invasion, and degree of differentiation
30. Flow cytometric DNA analysis of stage I endometrial carcinoma
31. DNA content as a prognostic factor in endometrial carcinoma
32. Ploidy disturbances as an early indicator of intrinsic malignancy in endometrial carcinoma
33. Pretreatment assessment of prognostic indicators in endometrial cancer